Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 106024586 | 10602458 | 6 | F | 20141028 | 20160905 | 20141124 | 20160913 | EXP | PHHY2014VE148720 | NOVARTIS | 62.62 | YR | F | Y | 0.00000 | 20160913 | CN | COUNTRY NOT SPECIFIED | VE |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 106024586 | 10602458 | 1 | PS | TASIGNA | NILOTINIB | 1 | Oral | 400 MG, QD | Y | U | 22068 | 400 | MG | CAPSULE | QD | ||||
| 106024586 | 10602458 | 2 | SS | SPRYCEL | DASATINIB | 1 | Unknown | 50 MG, UNK | Y | 0 | 50 | MG | |||||||
| 106024586 | 10602458 | 3 | C | LANTUS | INSULIN GLARGINE | 1 | Unknown | U | 0 | ||||||||||
| 106024586 | 10602458 | 4 | C | CLAVIDUR /00756801/ | 2 | Unknown | 75 MG, UNK | U | 0 | 75 | MG | ||||||||
| 106024586 | 10602458 | 5 | C | PLAVIX | CLOPIDOGREL BISULFATE | 1 | Unknown | 75 MG, QD | U | 0 | 75 | MG | QD | ||||||
| 106024586 | 10602458 | 6 | C | ASPIRIN. | ASPIRIN | 1 | Unknown | 81 MG, QD | U | 0 | 81 | MG | QD | ||||||
| 106024586 | 10602458 | 7 | C | ASPIRIN. | ASPIRIN | 1 | Unknown | U | 0 | ||||||||||
| 106024586 | 10602458 | 8 | C | LIPITOR | ATORVASTATIN CALCIUM | 1 | Unknown | 20 MG, QD | Y | 0 | 20 | MG | QD | ||||||
| 106024586 | 10602458 | 9 | C | LIPITOR | ATORVASTATIN CALCIUM | 1 | Unknown | 40 MG, QD | Y | 0 | 40 | MG | QD | ||||||
| 106024586 | 10602458 | 10 | C | LIPITOR | ATORVASTATIN CALCIUM | 1 | Unknown | 20 MG, UNK | Y | 0 | 20 | MG | |||||||
| 106024586 | 10602458 | 11 | C | JANUVIA | SITAGLIPTIN PHOSPHATE | 1 | Unknown | 50 MG, UNK | U | 0 | 50 | MG | |||||||
| 106024586 | 10602458 | 12 | C | CONCOR | BISOPROLOL FUMARATE | 1 | Unknown | 2.5 MG, UNK | U | 0 | 2.5 | MG | |||||||
| 106024586 | 10602458 | 13 | C | LASIX | FUROSEMIDE | 1 | Unknown | 20 MG, UNK | U | 0 | 20 | MG | |||||||
| 106024586 | 10602458 | 14 | C | ALDACTONE | SPIRONOLACTONE | 1 | Unknown | 25 MG, UNK | U | 0 | 25 | MG | |||||||
| 106024586 | 10602458 | 15 | C | DILATREND | CARVEDILOL | 1 | Unknown | 12.5 MG, QD | Y | 0 | 12.5 | MG | QD | ||||||
| 106024586 | 10602458 | 16 | C | DILATREND | CARVEDILOL | 1 | Unknown | 75 MG, BID | Y | 0 | 75 | MG | BID | ||||||
| 106024586 | 10602458 | 17 | C | DILATREND | CARVEDILOL | 1 | Unknown | 12.5 MG, UNK | Y | 0 | 12.5 | MG |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 106024586 | 10602458 | 1 | Chronic myeloid leukaemia |
| 106024586 | 10602458 | 2 | Product used for unknown indication |
| 106024586 | 10602458 | 3 | Chronic myeloid leukaemia |
| 106024586 | 10602458 | 4 | Cardiac disorder |
| 106024586 | 10602458 | 5 | Cardiac disorder |
| 106024586 | 10602458 | 6 | Cardiac disorder |
| 106024586 | 10602458 | 7 | Product used for unknown indication |
| 106024586 | 10602458 | 8 | Blood cholesterol abnormal |
| 106024586 | 10602458 | 9 | Blood triglycerides abnormal |
| 106024586 | 10602458 | 11 | Diabetes mellitus |
| 106024586 | 10602458 | 12 | Product used for unknown indication |
| 106024586 | 10602458 | 13 | Product used for unknown indication |
| 106024586 | 10602458 | 14 | Product used for unknown indication |
| 106024586 | 10602458 | 15 | Myocardial infarction |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 106024586 | 10602458 | OT |
| 106024586 | 10602458 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 106024586 | 10602458 | Chest pain | |
| 106024586 | 10602458 | Depressed mood | |
| 106024586 | 10602458 | Gait disturbance | |
| 106024586 | 10602458 | Limb discomfort | |
| 106024586 | 10602458 | Malaise | |
| 106024586 | 10602458 | Myocardial infarction | |
| 106024586 | 10602458 | Neoplasm | |
| 106024586 | 10602458 | Pulmonary oedema | |
| 106024586 | 10602458 | Rash generalised | |
| 106024586 | 10602458 | Rash papular | |
| 106024586 | 10602458 | Vomiting |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 106024586 | 10602458 | 1 | 20141027 | 0 | ||
| 106024586 | 10602458 | 15 | 20141029 | 0 | ||
| 106024586 | 10602458 | 17 | 20141029 | 0 |